Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in nonchemotherapy-pretreated patients

Ronald de Wit, Wim Kruit, Gerrit Stoter, M Boer-Dennert, J Kerger, Jaap Verweij

Research output: Contribution to journal › Article › Academic › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d09a3a7b8f524d8a91aa04aec8a86cb5,

title = "Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in nonchemotherapy-pretreated patients",

author = "{de Wit}, Ronald and Wim Kruit and Gerrit Stoter and M Boer-Dennert and J Kerger and Jaap Verweij",

year = "1998",

language = "Undefined/Unknown",

volume = "78",

pages = "1342--1345",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "10",

}

In: British Journal of Cancer, Vol. 78, No. 10, 1998, p. 1342-1345.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in nonchemotherapy-pretreated patients

AU - de Wit, Ronald

AU - Kruit, Wim

AU - Stoter, Gerrit

AU - Boer-Dennert, M

AU - Kerger, J

AU - Verweij, Jaap

PY - 1998

Y1 - 1998

M3 - Article

VL - 78

SP - 1342

EP - 1345

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 10

ER -